DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Fielding AK, Rowe JM, Buck G. et al.
UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia.
Blood 2014;
123 (06) 843-850
We do not assume any responsibility for the contents of the web pages of other providers.